This page lists the SEC filings reported by Carmignac Gestion.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2023-02-13 | Carmignac Gestion | Clearside Biomedical, Inc. | 2,400,344 | 4.0% | EDGAR |
SC 13G/A | 2022-02-09 | Carmignac Gestion | Clearside Biomedical, Inc. | 3,124,252 | 5.2% | EDGAR |
SC 13G | 2021-02-12 | Carmignac Gestion | Clearside Biomedical, Inc. | 3,540,961 | 7.3% | EDGAR |
SC 13G/A | 2019-02-13 | Carmignac Gestion | GrubHub Inc. | 2,485,816 | 2.7% | EDGAR |
SC 13G/A | 2019-02-13 | Carmignac Gestion | MERCADOLIBRE INC | 952,452 | 2.1% | EDGAR |
SC 13G/A | 2018-02-06 | Carmignac Gestion | MERCADOLIBRE INC | 2,308,664 | 5.2% | EDGAR |
SC 13G/A | 2018-02-06 | Carmignac Gestion | INTERCEPT PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G | 2018-02-06 | Carmignac Gestion | GrubHub Inc. | 5,261,716 | 6.1% | EDGAR |
SC 13G/A | 2017-02-07 | Carmignac Gestion | INTERCEPT PHARMACEUTICALS INC | 2,022,792 | 8.2% | EDGAR |
SC 13G/A | 2017-02-07 | Carmignac Gestion | Santander Mexico Financial Group, S.A.B. de C.V. | 103,770,135 | 3.2% | EDGAR |
SC 13G | 2017-02-07 | Carmignac Gestion | MERCADOLIBRE INC | 2,383,523 | 5.4% | EDGAR |
SC 13G/A | 2016-02-09 | Carmignac Gestion | INTERCEPT PHARMACEUTICALS INC | 1,319,887 | 5.4% | EDGAR |
SC 13G/A | 2016-02-09 | Carmignac Gestion | Groupon, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2016-02-09 | Carmignac Gestion | Santander Mexico Financial Group, S.A.B. de C.V. | 222,612,290 | 6.7% | EDGAR |
SC 13G/A | 2015-02-09 | Carmignac Gestion | Santander Mexico Financial Group, S.A.B. de C.V. | 217,249,670 | 6.5% | EDGAR |
SC 13G | 2015-02-09 | Carmignac Gestion | INTERCEPT PHARMACEUTICALS INC | 1,432,071 | 6.7% | EDGAR |
SC 13G | 2015-02-09 | Carmignac Gestion | Groupon, Inc. | 47,255,034 | 7.1% | EDGAR |
SC 13G | 2014-02-14 | Carmignac Gestion | Santander Mexico Financial Group, S.A.B. de C.V. | 179,996,220 | 5.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.